Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| May 11, 2026 | Capital Blue Cross | Knee BracesPayerPolicy · CAPBLUE-MP-6.012 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Kidney Transplants, Pancreas Transplants, and Simultaneous Kidney/Pancreas TransplantPayerPolicy · CAPBLUE-MP-9.005 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | KIF6 Genotyping for Predicting Cardiovascular Risk and/or Effectiveness of Statin TherapyPayerPolicy · CAPBLUE-MP-2.309 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | JAK2, MPL, and CLR Mutation Analysis in Myeloproliferative NeoplasmsPayerPolicy · CAPBLUE-MP-2.281 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Isolated Small Bowel Transplant and Small Bowel/Liver and Multivisceral TransplantPayerPolicy · CAPBLUE-MP-9.013 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Islet TransplantationPayerPolicy · CAPBLUE-MP-9.012 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Irreversible Electroporation of Tumors Located in the Liver, Pancreas, Kidney or LungPayerPolicy · CAPBLUE-MP-1.162 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Investigational Physical Medicine And Specialized Physical Medicine Interventions (Outpatient)PayerPolicy · CAPBLUE-MP-8.001 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Investigational Miscellaneous Genetic and Molecular TestsPayerPolicy · CAPBLUE-MP-2.277 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Invasive Prenatal (Fetal) Diagnostic TestingPayerPolicy · CAPBLUE-MP-2.278 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Intravitreal and Punctum Corticosteroid ImplantsPayerPolicy · CAPBLUE-MP-2.159 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Intravenous Chelation TherapyPayerPolicy · CAPBLUE-MP-4.005 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric DisordersPayerPolicy · CAPBLUE-MP-2.167 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Intraoperative Neurophysiologic Monitoring (Sensory Evoked Potentials, Motor Evoked Potentials, EEG Monitoring)PayerPolicy · CAPBLUE-MP-2.030 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Intraocular Radiotherapy for Age-Related Macular DegenerationPayerPolicy · CAPBLUE-MP-2.389 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Intraocular Lenses, Spectacle Correction,and Iris ProsthesisPayerPolicy · CAPBLUE-MP-6.058 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Interferential Current StimulationPayerPolicy · CAPBLUE-MP-6.047 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Intensive Pediatric Feeding ProgramsPayerPolicy · CAPBLUE-MP-2.079 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Inpatient Interfacility TransfersPayerPolicy · CAPBLUE-MP-3.019 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Injectable Bulking Agents for the Treatment of Urinary and Fecal IncontinencePayerPolicy · CAPBLUE-MP-4.012 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Implantation of Intrastromal Corneal Ring SegmentsPayerPolicy · CAPBLUE-MP-1.044 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Implantable Bone-Conduction and Bone-Anchored Hearing Prosthetic DevicesPayerPolicy · CAPBLUE-MP-1.019 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Hyperthermic Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic MalignanciesPayerPolicy · CAPBLUE-MP-2.021 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Hyperbaric Oxygen Therapy (HBO) (Formerly Hyperbaric Oxygen Pressurization)PayerPolicy · CAPBLUE-MP-2.070 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Hospital Beds and AccessoriesPayerPolicy · CAPBLUE-MP-6.001 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation in the Treatment of Germ-Cell TumorsPayerPolicy · CAPBLUE-MP-9.052 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Waldenstrom MacroglobulinemiaPayerPolicy · CAPBLUE-MP-9.046 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Solid Tumors of ChildhoodPayerPolicy · CAPBLUE-MP-9.054 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Primary AmyloidosisPayerPolicy · CAPBLUE-MP-9.045 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Plasma Cell Dyscrasias, Including Multiple Myeloma and POEMS SyndromePayerPolicy · CAPBLUE-MP-9.044 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Non-Hodgkin LymphomasPayerPolicy · CAPBLUE-MP-9.042 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in AdultsPayerPolicy · CAPBLUE-MP-9.048 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Hodgkin LymphomaPayerPolicy · CAPBLUE-MP-9.043 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Epithelial Ovarian CancerPayerPolicy · CAPBLUE-MP-9.047 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Chronic Myeloid LeukemiaPayerPolicy · CAPBLUE-MP-9.039 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaPayerPolicy · CAPBLUE-MP-9.038 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for CNS Embryonal Tumors and EpendymomaPayerPolicy · CAPBLUE-MP-9.050 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Autoimmune DiseasesPayerPolicy · CAPBLUE-MP-9.053 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaPayerPolicy · CAPBLUE-MP-9.040 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Hematopoietic Cell Transplantation for Acute Lymphoblastic LeukemiaPayerPolicy · CAPBLUE-MP-9.041 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Heart/Lung TransplantPayerPolicy · CAPBLUE-MP-9.014 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Heart TransplantPayerPolicy · CAPBLUE-MP-9.007 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Handheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins During Breast Conserving SurgeryPayerPolicy · CAPBLUE-MP-5.055 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | H-Wave Electrical StimulationPayerPolicy · CAPBLUE-MP-6.049 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Germline Genetic Testing for Pancreatic Cancer Susceptibility GenesPayerPolicy · CAPBLUE-MP-2.392 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Germline Genetic Testing for Hereditary Diffuse Gastric Cancer (CDH1,CTNNA1)PayerPolicy · CAPBLUE-MP-2.384 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Germline Genetic Testing for Hereditary Breast/Ovarian Cancer Syndrome and Other High-Risk Cancers (BRCA1, BRCA2, PALB2)PayerPolicy · CAPBLUE-MP-2.211 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Germline Genetic Testing for Gene Variants Associate with Breast Cancer in Individuals at High Breast Cancer Risk (CHEK2, ATM, and BARD1)PayerPolicy · CAPBLUE-MP-2.279 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Germline And Somatic Biomarker Testing (Including Liquid Biopsy) For Targeted Treatment In Prostate Cancer (Brca1/2, Homologous Recombination Repair Gene Alterations, Ntrk Gene Fusion)PayerPolicy · CAPBLUE-MP-2.394 | Metadata changed |
|---|
| May 11, 2026 | Capital Blue Cross | Germline And Somatic Biomarker Testing (Including Liquid Biopsy) For Targeted Treatment In Ovarian Cancer (Brca1, Brca2, Homologous Recombination Deficiency, Ntrk)PayerPolicy · CAPBLUE-MP-2.395 | Metadata changed |
|---|